Nisa Investment Advisors’s AbbVie ABBV Stock Holding History

Nisa Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$104M	Sell	479,659 -203,062	-30%	-$45M	0.39%	23
2025 Q4	$156M	Buy	682,721 +204,761	+43%	+$46.6M	0.51%	16
2025 Q3	$111M	Buy	477,960 +4,315	+0.9%	+$879K	0.43%	27
2025 Q2	$87.9M	Sell	473,645 -1,348	-0.3%	-$251K	0.4%	33
2025 Q1	$99.5M	Sell	474,993 -26,923	-5%	-$5.23M	0.5%	29
2024 Q4	$89.2M	Sell	501,916 -65,310	-12%	-$12M	0.35%	35
2024 Q3	$112M	Buy	567,226 +18,610	+3%	+$3.47M	0.66%	22
2024 Q2	$94.1M	Buy	548,616 +31,753	+6%	+$5.26M	0.59%	22
2024 Q1	$94.1M	Buy	516,863 +39,308	+8%	+$6.77M	0.61%	22
2023 Q4	$74M	Sell	477,555 -9,514	-2%	-$1.39M	0.52%	31
2023 Q3	$72.6M	Sell	487,069 -34,386	-7%	-$5.05M	0.55%	28
2023 Q2	$70.3M	Buy	521,455 +10,658	+2%	+$1.56M	0.52%	30
2023 Q1	$81.4M	Buy	510,797 +24,640	+5%	+$3.77M	0.64%	22
2022 Q4	$78.6M	Sell	486,157 -17,749	-4%	-$2.72M	0.62%	20
2022 Q3	$67.8M	Buy	503,906 +28,859	+6%	+$4.14M	0.58%	26
2022 Q2	$72.8M	Sell	475,047 -15,148	-3%	-$2.31M	0.64%	24
2022 Q1	$79.5M	Buy	490,195 +19,697	+4%	+$2.86M	0.56%	27
2021 Q4	$64.4M	Sell	470,498 -23,296	-5%	-$2.75M	0.48%	42
2021 Q3	$53.3K	Sell	493,794 -32,468	-6%	-$3.71M	0.32%	65
2021 Q2	$59.3K	Sell	526,262 -15,579	-3%	-$1.75M	0.37%	51
2021 Q1	$58.6K	Sell	541,841 -14,040	-3%	-$1.5M	0.37%	54
2020 Q4	$59.6M	Sell	555,881 -47,836	-8%	-$4.6M	0.38%	56
2020 Q3	$52.9M	Sell	603,717 -10,099	-2%	-$951K	0.43%	47
2020 Q2	$60.3M	Buy	613,816 +122,672	+25%	+$10.8M	0.55%	36
2020 Q1	$37.4M	Sell	491,144 -6,200	-1%	-$528K	0.42%	54
2019 Q4	$44M	Sell	497,344 -23,615	-5%	-$1.96M	0.38%	54
2019 Q3	$39.4M	Sell	520,959 -33,991	-6%	-$2.33M	0.35%	56
2019 Q2	$40.4M	Sell	554,950 -5,377	-1%	-$423K	0.38%	56
2019 Q1	$45.2M	Buy	560,327 +19,083	+4%	+$1.56M	0.44%	49
2018 Q4	$49.9M	Sell	541,244 -20,354	-4%	-$1.79M	0.56%	38
2018 Q3	$53.1M	Buy	561,598 +7,953	+1%	+$754K	0.48%	43
2018 Q2	$51.3M	Sell	553,645 -6,749	-1%	-$659K	0.53%	38
2018 Q1	$55.4M	Buy	560,394 +8,730	+2%	+$959K	0.58%	33
2017 Q4	$53.4M	Buy	551,664 +7,316	+1%	+$689K	0.55%	41
2017 Q3	$48.4M	Sell	544,348 -6,768	-1%	-$515K	0.54%	40
2017 Q2	$39.4M	Sell	551,116 -36,759	-6%	-$2.47M	0.46%	41
2017 Q1	$38.3M	Buy	587,875 +10,842	+2%	+$682K	0.46%	42
2016 Q4	$36.1M	Sell	577,033 -23,994	-4%	-$1.46M	0.44%	46
2016 Q3	$37.9M	Sell	601,027 -30,913	-5%	-$2M	0.49%	42
2016 Q2	$39.1M	Buy	631,940 +100,674	+19%	+$6.13M	0.53%	42
2016 Q1	$30.3M	Buy	531,266 +28,222	+6%	+$1.57M	0.44%	43
2015 Q4	$29.8M	Buy	503,044 +13,039	+3%	+$751K	0.43%	48
2015 Q3	$27M	Buy	490,005 +3,672	+0.8%	+$239K	0.41%	52
2015 Q2	$32.7M	Sell	486,333 -19,539	-4%	-$1.28M	0.46%	42
2015 Q1	$29.6M	Buy	505,872 +7,000	+1%	+$423K	0.41%	54
2014 Q4	$32.6M	Sell	498,872 -69,339	-12%	-$4.37M	0.45%	47
2014 Q3	$32.8M	Sell	568,211 -4,600	-0.8%	-$255K	0.46%	46
2014 Q2	$32.3M	Sell	572,811 -41,076	-7%	-$2.15M	0.45%	47
2014 Q1	$31.6M	Sell	613,887 -11,298	-2%	-$571K	0.45%	47
2013 Q4	$33M	Sell	625,185 -17,310	-3%	-$851K	0.47%	46
2013 Q3	$28.7M	Sell	642,495 -41,529	-6%	-$1.84M	0.44%	51
2013 Q2	$28.3M	Buy	+684,024	New	+$29.9M	0.44%	51

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nisa Investment Advisors's ABBV Position: Q1 2026 in Review

Nisa Investment Advisors reduced its AbbVie (ABBV) stake by 30% in Q1 2026, selling an estimated $45M and leaving 479,659 shares worth $104M. The position accounts for 0.39% of the portfolio, ranked #23.

Nisa Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $156M in Q4 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Nisa Investment Advisors held 479,659 shares of AbbVie worth $104M as of Q1 2026.
Nisa Investment Advisors sold 203,062 AbbVie shares in Q1 2026, an estimated $45M.
AbbVie made up 0.39% of Nisa Investment Advisors's portfolio in Q1 2026, its #23 holding.
Nisa Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Nisa Investment Advisors's AbbVie position peaked at $156M in Q4 2025.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.